- CEO
- Amnuay Oerareemitr
- Full Time Employees
- 500
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- 99/9 Moo 4, Ekachai Road Samut Sakhon Thailand 74000
- IPO Date
- Jul 27, 2016
- Business
- Ekachai Medical Care Public Company Limited (EKH.BK) operates Ekachai Hospital, a private general hospital in Thailand specializing in comprehensive inpatient and outpatient medical services; its core offerings include cosmetic surgery, EKI-IVF fertility and genetic treatments, ophthalmology, obstetrics and gynecology with pregnancy care and infertility technology, pediatrics, orthopedics with sports medicine and joint replacements, general surgery for conditions such as cysts, gallstones, hernias and hemorrhoids, 24/7 emergency care, health promotion checkups, hemodialysis with 14 stations, dental care, physical therapy, pre-employment and mobile checkups, internal medicine covering endocrinology, hematology, neurology and nephrology, aesthetic and dermatology with skin and laser treatments, child and teen development, and heart and vascular centers; the company also provides infertility and elderly care services alongside psychiatric and specialized elder hospitals through subsidiaries. Founded in 2003 and headquartered at 99/9 Moo 4 Ekachai Road, Khok Kham, Muang Samut Sakhon, Thailand, Ekachai Medical Care serves patients primarily in the greater Bangkok area and central Thailand regions with 100 inpatient beds and capacity for up to 1,000 outpatients daily across its six-story facility. Recent developments include an ongoing share repurchase program for financial management purposes initiated in early 2025 and continuing through mid-2025 with multiple reporting filings, completion of a share repurchase project in July 2025, director resignations and appointments including a new Chairman of the Board and Audit Committee changes in May 2025, establishment of a new subsidiary and financial assistance to subsidiaries in August 2024, disposition of investment in The Klinique Medical Clinic Public Company Limited in May 2024, and multiple capital increases from private placements and warrant exercises (EKH-W1) with new shares traded as recently as December 2024.